Screening for C283Y γ-Sarcoglycan Mutation in a High-Risk Group of Bulgarian Gypsies: Evidence for a Geographical Localization and a Non-Random Distribution among Gypsy Subgroups

By  

Public Health Genomics, Vol. 5, Iss. 4, 2002-12 ,pp. : 217-221

Karger

Access to resources Recommend Favorite

Mutations That Disrupt the Carboxyl-Terminus of γ-Sarcoglycan Cause Muscular Dystrophy

By McNally Elizabeth M.   Duggan David   Rafael Gorospe J.   Bönnemann Carsten G.   Fanin Marina   Pegoraro Elena   Lidov Hart G. W.   Noguchi Satoru   Ozawa Eijiro   Finkel Richard S.   Cruse Robert P.   Angelini Corrado   Kunkel Louis M.   Hoffman Eric P.  

Human Molecular Genetics, Vol. 5, Iss. 11, 1996-11 ,pp. : 1841-1847

Oxford University Press

Access to resources Recommend Favorite

Identification of a Founder Mutation in the Protoporphyrinogen Oxidase Gene in Variegate Porphyria Patients from Chile

By  

Human Heredity, Vol. 51, Iss. 3, 2001-01 ,pp. : 160-168

Karger

Access to resources Recommend Favorite

Ancestral Founder of Mutation W283X in the Porphobilinogen Deaminase Gene among Acute Intermittent Porphyria Patients

By  

Human Heredity, Vol. 54, Iss. 2, 2003-01 ,pp. : 69-81

Karger

Access to resources Recommend Favorite

A 1,100-year-old founder effect mutation in IL12B gene is responsible for Mendelian susceptibility to mycobacterial disease in Tunisian patients

By Ben-Mustapha Imen   Ben-Ali Meriem   Mekki Najla   Patin Etienne   Harmant Christine   Bouguila Jihène   Elloumi-Zghal Houda   Harbi Abdelaziz   Béjaoui Mohamed   Boughammoura Lamia   Chemli Jalel   Barbouche Mohamed-Ridha  

Immunogenetics, Vol. 66, Iss. 1, 2014-01 ,pp. : 67-71

Springer Publishing Company

Access to resources Recommend Favorite